` AMED (Amedisys Inc) vs S&P 500 Comparison - Alpha Spread

AMED
vs
S&P 500

Over the past 12 months, AMED has outperformed S&P 500, delivering a return of +19% compared to the S&P 500's +14% growth.

Stocks Performance
AMED vs S&P 500

Loading
AMED
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
AMED vs S&P 500

Loading
AMED
S&P 500
Difference
www.alphaspread.com

Performance By Year
AMED vs S&P 500

Loading
AMED
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Amedisys Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Amedisys Inc
Glance View

Amedisys Inc., headquartered in Baton Rouge, Louisiana, has crafted its narrative at the forefront of America's healthcare sector, by focusing squarely on providing quality home health and hospice services. Established in 1982, the company has steadily expanded its reach, now operating in more than 30 states with a strong network of healthcare professionals dedicated to delivering comprehensive care at the patient's doorstep. Amedisys identifies the growing preference for home-based care among patients and leverages this trend by offering services in home health, hospice, and personal care. This strategic focus aligns with the nationwide shift towards value-based care, where healthcare providers are rewarded for the quality and effectiveness of care given to patients rather than volume. The company's financial engine thrives on two primary service lines: home health and hospice care. Home health services are Amedisys’s backbone, generating revenue by providing skilled medical care and support services at home to patients recovering from illnesses, surgeries, or those managing chronic diseases. Their clinicians, comprising nurses and therapists, work closely with patients to ensure a personalized care plan tailored to individual needs. Hospice care, on the other hand, caters to terminally ill patients, offering support that prioritizes comfort and quality of life in their final days. By understanding the intricacies of Medicare, Medicaid, and private insurance billing, Amedisys efficiently navigates reimbursement pathways, ensuring steady cash flow while aligning with regulatory requirements. This operational model not only feeds into Amedisys's financial health but also solidifies its role as a crucial player in the evolving landscape of at-home healthcare services.

AMED Intrinsic Value
114.35 USD
Undervaluation 12%
Intrinsic Value
Price
Back to Top